Aim: To study surgical outcome in dacryocystorhinostomy (DCR) stent insertion in initial endoscopic DCR and the complications associated with the surgery.
INTRODUCTION
Dacryocystorhinostomy (DCR) is a procedure performed to drain the lacrimal sac in cases of nasolacrimal duct obstruction. It can be performed externally or endoscopically.
1,2 The evolution of lacrimal surgery began around 2250 bc, where the code of Hammurabi made first reference to surgical treatment of lacrimal fistula. 3 In 1893,
Caldwell described the first intranasal DCR 1-3 ; Donogh and Meiring described endoscopic DCR. 2, 3 Since then, many modifications have occurred in DCR surgeries. 1, 3 Currently, lacrimal stenting is done to enhance the results of the surgery. 4 Presently, stenting is done in revision cases. On the other hand, some studies indicate that silicone stent itself is a reason for surgical failure due to granulation tissue formation and complications like punctual erosion and slitting of canaliculi. 4 But now, good quality stents are available in the market, which rarely cause granulation and other problems. Hence, the study is carried out to know the surgical outcome of stenting at initial surgery so as to know whether good results can be obtained.
AIM
• To study the surgical outcome in DCR stent insertion in initial endoscopic DCR.
• To study the complications associated with surgery.
MATERIALS AND METHODS

Study Subjects
This is a prospective, single-blinded, randomized study conducted in a tertiary level center from November 2009 to February 2015.
The participants of the study are the patients who attended the outpatient department of the Department of Otorhinolaryngology and Ophthalmology. Ethical clearance was obtained from the ethical committee.
Inclusion Criteria
Inclusion criteria include patients with symptoms of nasolacrimal obstruction, which is not relieved by probing and syringing. All patients presented with history of epiphora. They were given antibiotics for 15 days prior to surgery. A detailed history was taken. The local eye examination and diagnostic nasal endoscopy were done. The patients were explained about the procedure, and written consent was obtained. The ophthalmologist performed probing and syringing. The computed tomography (CT) dacryocystogram was not done in any of the patients.
A total of 50 patients were randomly grouped into two groups of 25 each, one group for undergoing endoscopic DCR without stents and the other for endoscopic DCR with stents.
Surgical Technique
Premedication inj. Fortwin 30 mg and inj. Phenergan 50 mg were given half an hour prior to surgery intramuscularly, intragluteally. The procedure was performed under local anesthesia. The head end of the table was elevated to 30°, and the nose was packed with 4% xylocaine half an hour prior to the procedure. This gave mucosal anesthesia. Supratrochlear, supraorbital, infraorbital, and anterior ethmoidal nerve block was given with 1% xylocaine in 1:400,000 adrenaline. Local anesthesia was also injected near the axilla of uncinate process and maxillary line. Surgery was performed using 0 and 30 endoscopes. An inverted U-shaped incision was made in the lateral wall of the nasal cavity anterior and superior to the anterior attachment of middle turbinate with the help of sickle knife. The mucosal flap was elevated with Freer's elevator to expose the bone overlying the lacrimal sac. The mucosal flap was removed with the help of straight Blakesley forceps. The exposed bone, overlying the lacrimal sac, was gently drilled by cutting burr (3 mm) and with Kerrison rongeur. Bone was removed to the extent of approximately 1.0 × 1.5 cm, and lacrimal sac was exposed. Medial wall of the sac was incised with sickle knife and removed. Opening of the sac was confirmed by injecting 1% betadine solution. In 25 patients, the aurolac lacrimal intubation sets were passed through superior and inferior canaliculi, and ends of the tube were tied in the nose. Antibiotic ointment was applied in the eye. A small neomycin wick was kept in nose for 4 hours. All patients were discharged on regime of oral antibiotics and anti-inflammatory drugs and local antibiotic eye drops. Patients were followed up after 1 week, and then at 3 months and later at 6 months. Patient's lacrimal stent was removed at the end of the 3rd month in whom it had been inserted.
Evaluation
The Royal College of Ophthalmologists published guidelines for clinical governance, which suggests that freedom from epiphora 3 months after surgery is the marker for satisfactory procedure. 5 Hence, subjective and objective assessments were done at the end of 3rd and 6th month interval. Subjective evaluation was made by questionnaire in terms of complete/partial/no relief from symptoms. Objective evaluation was done by syringing at the end of 3rd and 6th month. Shrestha et al, 2 Kakkar et al, 4 and
Yung and Hardman-Lea 6 have categorized the success rate of endoscopic DCR into complete cure, partial cure, and no improvement depending upon sac syringing. The present study also employs the same criteria for objective evaluation. The results were evaluated as follows:
• Complete cure means patent: There was no resistance to the flow of the fluid through sac to nasopharynx.
• Partial cure means partially patent: When some of the fluid regurgitated through the upper punctum and some passed into nasopharynx.
• No cure means blocked: When whole of the fluid regurgitated through the upper punctum and no fluid passed into the nasopharynx.
Data Analysis
Chi-square test was applied to evaluate the results; p-value of 0.05 was considered as statistically significant.
RESULTS
In the present study, the age group between 11 and 60 years was included. In endoscopic DCR without stent group, the youngest patient was 18 years and oldest was 54 years. In endoscopic DCR with stent group, the youngest patient was 19 years and oldest was 59 years. The majority of patients in both groups were between ages 40 and 50 years, i.e., 50%.
In the present study, there were 15 males and 35 females, showing female predilection. A total of 15 patients underwent left-sided DCR and 10 patients underwent right-sided DCR in endoscopic DCR without stent group. In endoscopic DCR with stent group, 14 patients underwent left-sided DCR and 11 patients underwent right-sided DCR.
Intraoperatively, in without stent group, mucoid discharge was seen in 12% (n = 3), mucopurulent discharge was seen in 32% (n = 8), purulent discharge was seen in 48% (n = 12), and atrophic sac was seen in 8% (n = 2) of patients. In stent group, mucoid discharge was seen in 8% (n = 2), mucopurulent discharge was seen in 32% (n = 8), purulent discharge was seen in 44% (n = 11), and atrophic sac was seen in 16% (n = 4) of patients.
Subjectively, at 3 months in without stent group, 17 patients had complete relief, 6 patients had partial relief, and 2 patients had no relief. At the end of 6 months, 17 patients had complete relief, 4 patients had partial relief, and 4 patients had no relief. In patients with stent, at the end of 3 months, 25 patients had complete relief after the removal of stent. At the end of 6 months, 22 patients had complete relief, 1 patient had partial relief, and 2 had no relief. Chi-square values of 9.5 and 3.11 were obtained at the end of 3 and 6 months respectively (Table 1) .
Objectively, in patients without stent at the end of 3 months, 21 patients had complete cure, 2 had partial cure, and 2 had no cure. At the end of 6 months, 18 patients had complete cure, 3 had partial cure, and 4 had no cure. In patients with stent, at the end of 3 months, 23 had complete cure and 2 had no cure. After 6 months, 21 had complete cure, 2 had partial cure, and 2 had no cure. Chi-square values of 2.09 and 1.09 were obtained at the end of 3 and 6 months respectively (Table 2) .
Regarding complications in without stent group, 12% (n = 3) had synechia as the most common complication, 8% (n = 2) had secondary hemorrhage, and 8% (n = 2) had rhinostomy closure at the end of 6 months. In stent group, secondary hemorrhage occurred in 12% (n = 3) of patients followed by difficulty in removal of stent in 4% (n = 1) of cases.
DISCUSSION
Endoscopic DCR is a commonly performed operation in which a fistulous tract is created between the lacrimal sac and the nasal cavity in order to relieve the epiphora due to nasolacrimal duct obstruction. Wormald 7 had demonstrated that approximately two thirds of the lacrimal sac is above the axilla of the middle turbinate. Therefore, during DCR surgery, in order to accomplish complete sac exposure, a large amount of thick bone over the axilla of the middle turbinate and the lateral wall of the agger nasi has to be removed. The size of the lacrimal ostium created during endoscopic DCR is paramount to the success of this surgery. 1 There are other factors like accurate anatomical knowledge of lacrimal sac area, which governs the result of the surgery. Studies of intranasal anatomy of the lacrimal sac have shown that the rhinostomy needs to be larger and higher on the lateral wall than previously thought; as a result, the upper half of the sac is behind the thick bone of the frontal process of the maxilla. 1 Silicone stent has been proposed to maintain the patency of fistula during postoperative healing period. a selective stenting approach for primary endoscopic DCR, whereby stents are only inserted when a tight common canaliculus opening is found during surgery. 
AIJCR
Singh et al, 10 Sham and van Hasselt, 11 Acharya et al, 12 and Kakkar et al 4 on the basis of their studies opined that silicone stenting is not routinely indicated in endoscopic DCR, as there was no difference with stent and without stent. Additionally, the use of stent is associated with patient discomfort, increased risk of complications, and additional cost. 4 In the present study, the majority of patients in both groups were between ages 40 and 50 years. In the study of Vishwakarma et al, 3 most of them were in the age group of 31 to 50. In Harvinder et al 1 study, the mean age was 45.54 years (18-74 years). In Kakkar et al 4 study, the age of the patients ranged from 16 to 60 years, with the most common age group affected being 21 to 30 years. The mean age in the study was 33.8 years.
In the present study, there were 15 males and 35 females, showing female predilection. This correlates with other studies. In Vishwakarma et al 3 success rate in the without stent group. 13 In the present study, the success rate of endoscopic DCR with stent is 92% at the end of 6 months. Jin The synechia formed in the nonstent group was released under the guidance of endoscope. Secondary hemorrhage, which occurred in both groups, was managed conservatively by nasal packing for 24 hours. Closure of rhinostomy occurred in 2 patients, and one among the two also had secondary hemorrhage. They were advised revision surgery. In stent group, secondary hemorrhage occurred in 12% of patients. This occurred in initial cases owing to learning curve while passing the metallic end of the stent, which caused abrasions in nasal mucosa. Difficulty in removal of stent occurred in 1 patient whose nasal end of stent was small. Postoperative discomfort, orbital fat exposure, corneal abrasion, canaliculi erosion, and tube prolapse from stent never occurred in the present study as high-quality stent was used with gentle handling.
In of rhinostomy opening was found to be obstructed by granulations or synechia in endoscopic DCR with stent. He reported bleeding from nasal cavity, orbital injury, CSF leakage through fractured ethmoid, corneal abrasion, canaliculi erosion due to overly tight silicone tube placement, and lacrimal pump syndrome associated with the use of stent.
CONCLUSION
The present study shows that statistically significant difference in results is not achieved by inserting stents initially. But, whenever there is excessive bleeding during surgery that masks endoscopic picture or when bony stoma created is small because of thick bone and poor access, when atrophic sac is present, or when adhesions are expected due to pus in sac, then stenting should be done without hesitancy. Best time to do stenting is when surgeons first think of stenting. Regular postoperative follow-up is necessary, as any defect like synechia and granulation tissue formation can be dealt with immediately.
